Abbott Laboratories (rights to Gabitril) Overview

  • Founded
  • 1998
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Abbott Laboratories (rights to Gabitril) General Information

Description

A drug manufacturing rights. The drug is a treatment for partial seizures related to epilepsy enabling patience in reducing the frequency of partial seizures when added to an existing regimen of at least one other antiepilepsy drug.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Acquirer
Primary Office
  • Chicago, IL
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Abbott Laboratories (rights to Gabitril) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Abbott Laboratories (rights to Gabitril)‘s full profile, request access.

Request a free trial

Abbott Laboratories (rights to Gabitril) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Abbott Laboratories (rights to Gabitril)‘s full profile, request access.

Request a free trial